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1. Introduction
Resective surgery has been demonstrated to be a successful
treatment option for patients with medically intractable
epilepsy1–3 resulting in seizure freedom for more than 70% of
patients.4–9 Unilateral resection of temporal lobe structures has
known risks to neurocognitive functions especially memory and
language.10–13 Numerous surgical approaches have been devel-
oped in part to reduce neurocognitive sequela associated with
resective surgery.8,14–16 Post-operative neurocognitive change
has been evaluated at the group level and by use of reliable change
scores which likely provide a more accurate indication of
statistically meaningful change.10,17–19
Mesial temporal lobe (MTL) surgery has known neurocognitive
risks which include potential decline in verbal memory, language
functions, and aspects of intellectual functions following dominant
MTL surgery as well as potential decline in non-verbal memory and
aspects of intellect following non-dominant MTL surgery.10,13,20–22
Dominant MTL surgery appears to present the greatest risk for
post-operative neurocognitive decline. Post-operative neurocog-
nitive change has often been evaluated at the group level;
however, use of reliable change scores may provide a more
accurate estimate of risk for post-operative decline by accounting
for test measurement error and practice effects.10,17–19 Without
use of reliable changes scores, lack of decline or presence of
improved performance may be due to practice effects from
repeated testing and/or measurement error. However, reliable
change scores have only been reported in a very small sample
following subtemporal selective amygdalohippocampectomy.8
Surgical approach to MTL resective surgery may have differential
effects on neurocognitive outcome.
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A B S T R A C T
Purpose: The present study provides a detailed account of neurocognitive outcome following minimal
access subtemporal selective amygdalohippocampectomy (SAH) and establishes rates of neurocognitive
decline in the largest sample to date. Use of a subtemporal surgical approach to SAH has been proposed to
possibly reduce the risk for postoperative neurocognitive decline since lateral neocortical tissues is not
resected and the temporal stem is preserved. The current study extends prior research with subtemporal
SAH patients to include not only group level analyses but also analyses based on reliable change data.
Methods: Neurocognitive comparisons are made between 47 patients that underwent subtemporal SAH.
Statistical comparisons were made between neurocognitive performance at the group level and with use
of reliable change scores.
Results: Approximately 75% of patients were seizure free postoperatively. At the group level, there were
no significant postoperative changes. For the left SAH patients, reliable change scores demonstrated a
decline in approximately one third of patients for memory, verbal intellect, and naming. Right SAH
patients showed decline primarily in memory.
Conclusions: These results indicated good seizure control following subtemporal SAH with greatest risk
for neurocognitive decline following dominant SAH and best cognitive outcome following non-dominant
SAH. Findings demonstrated the importance of reliable change analyses that make individual based
comparisons and take into account measurement error. Despite preservation of the lateral neocortical
tissue and the temporal stem, subtemporal SAH presents a risk for cognitive decline in a notable portion
of patients.
 2012 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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Selective amygdalohippocampectomy (SAH) for treatment of
MTL onset seizures has been used to minimize the amount of tissue
resected in a standard or modified anterior temporal lobectomy
(ATL) and potentially reduce post-operative neurocognitive
sequelae.8,16 The three approaches to SAH include transcortical,
transsylvian, and subtemporal.23 Subtemporal SAH may present a
lower risk for post-operative neurocognitive decline since it, (1)
minimizes the amount of neocortical tissue resected (unlike ATL),
(2) does not involve resection of potentially functional lateral
temporal neocortical tissue (unlike a transcortical approach), and
(3) does not involve transection of the temporal stem/uncinate
fasciculus which contains fibers connecting frontal and temporal
structures (unlike the transsylvian approach).8,24 Only a few
studies have evaluated post-operative neurocognitive outcome
following subtemporal SAH and all of those studies have had very
small samples sizes.8,25–29 In general, previous studies have shown
favorable neurocognitive outcome following subtemporal SAH
although, only Little et al.,8 attempted to account for statistically
reliable change as defined elsewhere.18,30 Therefore, a detailed
account of neurocognitive outcome using reliable change statistics
following subtemporal SAH with a sufficiently large sample
remains to be done.
The aim of the present study was to compare pre and post-
operative neurocognitive performance following subtemporal
SAH in the largest sample to date. Neurocognitive performance
was compared at the group level and with reliable change
scores. Dominant temporal lobe compared to non-dominant
temporal lobe SAH patients were expected to experience a
higher proportion of decline on measures of neurocognitive
function.
2. Methods
2.1. Patients and procedures
The present study was conducted at St. Joseph’s Hospital and
Medical Center, Phoenix, Arizona with approval of the institutional
review board (IRB). Data collection was considered exempt by the
institutions IRB since data (pre and post-operative) were obtained
as part of each patient’s standard clinical care. Obtained data were
archival and included consecutive patients seen for both preoper-
ative and postoperative neuropsychological evaluation from 2006
to 2011. At this institution, patients are typically referred for post-
operative evaluation 6–9 months following SAH. Patients included
in this study had focal onset mesial temporal lobe complex partial
seizures as established by video-electroencephalogram (V-EEG)
and clinical observation during epilepsy monitoring unit stay. A
total of 61 consecutive patients that underwent SAH (right n = 28
and left n = 33) were available for statistical comparison. Patients
were excluded if they had undergone surgical resection other than
subtemporal SAH (n = 4), had lesions other than MTS (n = 0), had
more than 50% missing data (n = 2), had right hemisphere or
bilateral speech dominance based on Wada testing (n = 2), or had a
post-operative neuropsychological evaluation greater than 12
months post SAH (right n = 2 and left n = 4). The final sample
included a total of 47 patients (right n = 22 and left n = 25) that
underwent subtemporal SAH. Minimal access subtemporal selec-
tive amygdalohippocampectomy involves keyhole access through
the zygoma to the temporal floor and requires minimal retraction.8
Cortical incision was through the fusiform gyrus or collateral
sulcus with subsequent resection of the majority of the amygdala,
head of the hippocampus, and body of the hippocampus. For a
thorough review of the minimal access subtemporal SAH surgical
technique please refer to Little et al.8
Patients included in this study completed preoperative
evaluation including inpatient V-EEG, brain MRI (most cases),
neuropsychological evaluation, and Wada test/intracarotid amo-
barbital test. Language dominance was established by Wada
testing. Postoperative neuropsychological evaluation was com-
pleted as an outpatient.
2.2. Pathology and seizure freedom
Variables of clinical interest included results from preoperative
brain magnetic resonance imaging (MRI), post-operative histopa-
thology if available, and post-operative seizure control. For
statistical purposes, evidence of MTS was considered present if
noted by MRI and/or histopathology. Results from brain MRI
(n = 47) were classified as showing unilateral right or left mesial
temporal sclerosis (MTS), bilateral MTS, or no MTS based on the
neuroradiologist’s clinical report. No patients were included if they
had presence of pathology other than MTS (e.g., neoplasm, cortical
dysplasia, etc.). Post-operative histopathology was available for 10
right SAH and 9 left SAH patients and presence of MTS was noted
based on the pathologist’s clinical report. Patients were classified
as being either seizure free or having recurrent seizures based on
report of the neurosurgeon 3 months post surgery and at the time
of the neuropsychological evaluation. Seizure freedom was defined
as no recurrent seizures. Recurrent seizures were defined as having
1 or more post-operative seizures. Assignment of Engle classifica-
tion was not possible due to the archival nature of the data and
insufficient information regarding the frequency and diurnal
occurrence of postoperative seizures.
2.3. Neuropsychological measures
Neuropsychological evaluation included measures of intellect,
processing speed, language, visuospatial functioning, executive
functioning, learning, memory, fine motor speed, and mood.
Intelligence was measured with the Wechsler Abbreviated Scale of
Intelligence (WASI31). On this measure, the Verbal Intelligence
Quotient (VIQ) is comprised of the Vocabulary and Similarities
subtests. The Performance Intelligence Quotient (PIQ) is comprised
of the Block Design and Matrix Reasoning subtests. All four
subtests are used to calculate the Full Scale Intelligence Quotient
(FSIQ). Exclusion of attention and processing speed measures in
calculation of intelligence quotients by the WASI is similar to the
newest version of the Wechsler Adult Intelligence Scale, or WAIS-
IV. Processing speed was assessed with the Wechsler Adult Scale of
Intelligence-III (WAIS-III32) Coding subtest and the Halstead-
Reitan Trail Making Test Part A (Trails A33). Attention was
measured with the WAIS-III Digit Span subtest.32 Confrontation
naming was assessed by the Boston Naming Test (BNT34).
Executive functioning was examined with the Halstead-Reitan
Trail Making Test Part B (Trails B33). The Rey-Auditory Verbal
Learning Test (RAVLT35) trials 1–5 total score was used to evaluate
verbal learning (Learning) and long delay total score was used to
measure verbal memory (Delay). The Brief Visuospatial Memory
Test-Revised (BVMT-R36) trials 1–3 total score was used to
evaluate nonverbal learning (Learning) and the delayed recall
total score was used to evaluate nonverbal memory (Delay). Fine
motor speed was tested with the Halstead-Reitan Finger Tapping
Test (FTT33) for the right and left hands. The Beck Depression
Inventory-II (BDI-II37) was used to measure depressive symptoms.
All test scores, with the exception of the BDI-II, were converted to
standardized scores based on published normative data. Standard
scores (SS) were used for the WASI indices, which have a mean of
100 and a standard deviation of 15. Age corrected scaled scores
(ACSS) were used for the WAIS-III subtests which have a mean of
10 and a standard deviation of 3. T-scores were used for Trails A
and B, BNT, RAVLT, BVMT-R, and FTT which have a mean of 50 and a
standard deviation of 10.
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2.4. Reliable change scores
Reliable change scores were calculated using the Jacobson and
Truax formula38 with correction for potential practice effect.10
Reliable change scores are standardized scores obtained by
correcting the simple difference between post-operative and
preoperative scores for the standard error of the difference and
practice effect. For details regarding the RCI equation please refer
to Jacobson & Truax 1991.38 A 90% confidence interval (CI) was
used in this study since it has been commonly used in epilepsy
research.10,17,18 The 90% CI allows for 5% chance of error on both
ends of the distribution. Similar to the methods of Baxendale and
Thompson,39 reliable change scores were derived from test–retest
data reported in the tests statistical manual for the WASI31 and
clinical samples for other tests (BVMT-R, 40 RAVLT & BNT,17 Digit
Span & Coding,19 and FTT & TMT41). Although it is preferable to
have test–retest data derived from an epilepsy sample with retest
delay at a similar interval to that of short-term outcome
evaluations (e.g., 3–12 months post first testing), test–retest data
from an epilepsy sample was not available for all measures.
However, even with shorter test–retest intervals, practice effects
were small and it would be unlikely that larger practice effects
would be obtained with longer retest time intervals. Consequently,
test–retest data used in the present study likely provided a
reasonable estimate of reliable change. Still, the most important
aspect of calculating reliable change scores is that it removes the
error in an individual’s score (performance) that is related to the
standard error of measurement unique to that test. Thus, reliable
change scores help estimate whether or not an individual’s
difference in performance between two time points, in this case
pre-operative versus post-operative performance, is significantly
different by taking into account each test’s reliability coefficient
and each test’s standard deviation.
2.5. Statistical analysis
Statistical analysis was completed by use of PASW 18.0 and SAS
software. Chi-square and Analysis of Variance (ANOVAs) were
used for comparison of patient’s demographics variables. Hotell-
ing T-squared was used to compare pre and post operative
neuropsychological performance at the group level with side of
SAH (right or left), presence/absence of MTS, and presence/
absence of post-operative seizures as between group variables.
Hotelling T-squared is similar to completing repeated measures
multivariate analysis of variance. Reliable change scores were
used to identify patients that showed a statistically significant
change or stable performance at the 90% CI as indicated by the
following scores: decline (change score < 1.64), stable perfor-
mance (1.65 < change score < 1.65), or gain (change
score > 1.64). Exploratory analysis, using ANOVA, compared rates
of impaired scores (1 SD from the normative mean) between
right and left SAH groups on the BVMT-R Learning and Delay as
well as the RAVLT-Learning and Delay.
3. Results
3.1. Demographics
There were no significant demographic differences between
right and left SAH groups with the exception of ethnicity (Table 1).
There were a significantly higher number of Hispanic patients in
the left compared to right SAH group. In this sample, most of the
patients were female and right handed with half of the patients
employed. On average, postoperative follow-up neurocognitive
evaluations were conducted approximately 7 months post-surgery
(M = 6.9, SD = 1.9) with a range of 3–11 months. By far, the majority
of patients (n = 37, 78.7%) were seen around 7 months (2 months)
post-operatively.
3.2. Pathology and seizure freedom
Evidence of MTS based on combined MRI results and
histopathology ipsilateral to side of SAH was non-significant
(see Table 2). Based on MRI, there were no patients with MTS
contralateral to SAH and there were no patients with bilateral MTS
or other pathologies.
Seizure freedom at an average of 7 months post SAH was
obtained in 74.5% of patients (right SAH n = 15 [68.2%]; left SAH
n = 20 [80%]) and did not statistically differ between SAH groups
(x2 = .0860, p = 0.354). A portion of the patients classified as having
recurrent seizures may in fact still be classified as Engle class 1
depending on the frequency of seizures and their diurnal variation;
however, these details were not available for all patients. Post-
operative seizure control did not statistically differ based on
presence or absence of MTS (F = 0.038, p = 0.846).
3.3. Mean group differences on neuropsychological tests
Descriptive statistics for pre and post operative neuropsycho-
logical test performance by side of SAH are presented in Table 3.
Based on Hotelling T-squared, there were no significant pre and
post-operative differences on neuropsychological measures at the
omnibus level when compared by side of SAH (F = 1.095;
p = 0.449), presence/absence of MTS (F = 0.255; p = 0.992), and
presence/absence of post operative seizures (F = 1.874; p = 0.148).
Results indicated at the group level there were no significant
changes in pre to post operative neuropsychological performance
Table 1
Post-operative demographics by seizure group.
Demographic Right SAH
(n = 22)
Left SAH
(n = 25)
F/x2 p
Age 34.6 (11.6) 39.9 (12.8) 2.14 0.15
Education (years) 13.3 (2.2) 13.2 (2.6) 0.00 0.92
Gender
Female 13 (59.1%) 18 (72%) 0.87 0.35
Male 9 (40.9%) 7 (28%)
Ethnicity
Caucasian 21 (95.5%) 15 (60%) 8.24 0.02
Hispanic 1 (4.5%) 9 (36%)
African American 0 (0%) 1 (4%)
Handedness
Right 20 (90.9%) 23 (92%) 0.02 0.89
Left 2 (9.1%) 2 (8%)
Employment
Unemployed/disability 9 (40.9%) 10 (40%) 0.02 0.99
Employed 12 (54.5%) 14 (56%)
School 1 (4.5%) 1 (4%)
Age at first seizure 14.4 (10.6) 15.3 (15.7) 0.05 0.82
Years since first seizure 20.2 (13.1) 24.9 (14.1) 1.33 0.25
Number of AED’s 1.7 (0.6) 1.8 (0.5) 0.04 0.85
Note: Means (SD) or frequencies (%) are reported for each variable. AEDs refers to
antiepileptic drugs.
Table 2
Mesial temporal pathology based on brain MRI and/or histopathology.
Variable Right SAH (n = 22) Left SAH (n = 25)
MTS Laterality
Right 20 (90.9%) 0 (0%)
Left 0 (0%) 20 (80%)
No MTS 2 (9.1%) 5 (20%)
Note: MTS = mesial temporal sclerosis based on brain MRI or post-operative
histopathology.
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when compared by right or left SAH, presence or absence of MTS, or
presence or absence of postoperative seizures.
3.4. Reliable change scores
Distribution of reliable change scores using a 90% CI were
qualitatively compared between right and left SAH groups (Table
4). By far, the majority of patients showed no decline on
neurocognitive measures post-operatively in either SAH group.
The highest proportion of patients demonstrating decline in the
right SAH group was on the BVMT-R Delay (nonverbal memory)
(36% of patients). The highest proportion of patients with decline
in the left SAH group was noted on the WASI VIQ (verbal intellect),
Trails A (processing speed), BNT (naming), and the BVMT-R
Learning and Delay (nonverbal) which occurred in approximately
21–39% of patients. A notable proportion of patients experienced a
statistically significant decline on a measure of nonverbal memory
(BVMT-R Delay) following both right and left SAH but minimal
decline on a test of verbal learning and memory (RAVLT). Time post
surgery in months did not significantly correlate with any of the
neuropsychological change scores.
3.5. Exploratory analysis
The percentage of patients with impaired scores (1 SD below
the normative mean) on learning and memory tests was evaluated
by ANOVA (Table 5). A significantly higher proportion of right SAH
compared to left SAH patients had preoperative impaired scores on
BVMT-Learning and Delay. A significantly higher proportion of left
compared to right SAH patients had preoperative impaired scores
on the RAVLT-Learning and Delay. Postoperatively, rates of
impaired BVMT-Learning and Delay did not significantly differ
between groups; however, more than half of right SAH patients
and less than half of left SAH patients had impaired scores.
Table 4
90% confidence interval reliable change results for neuropsychological tests.
Test Right SAH 90% CI Left SAH 90% CI
Decline Stable Improved Decline Stable Improved
WASI
FSIQ 10% 75% 15% 18.2% 81.8% 0%
VIQ 10% 80% 10% 38.1% 61.9% 0%
PIQ 10% 80% 10% 9.5% 90.5% 0%
WAIS-III
Digit Span 5.6% 94.4% 0% 4.2% 91.7% 4.2%
Coding 11% 78% 11% 8.7% 91.3% 0%
Trail Making Test
Trails A 9.5% 66.7% 23.8% 24% 52% 24%
Trails B 5.3% 84% 10.5% 4% 92% 4%
BNT 10% 75% 15% 39.1% 52.2% 8.7%
BVMT-R
Learning 4.5% 90.9% 4.5% 20.8% 75% 4%
Delay 36.4% 59.1% 4.5% 29.2% 66.7% 4.2%
RAVLT
Learning 0% 100% 0% 4.1% 91.7% 4.2%
Delay 0% 100% 0% 8% 88% 4%
Finger Tapping Test
Right 15% 75% 10% 5.3% 89.5% 5.3%
Left 15% 80% 5% 0% 90% 10%
Note: Percentage of cases is reported for each variable.
Table 3
Pre and post-operative neuropsychological results.
Test Right SAH (n = 22) Left SAH (n = 25)
Pre-operative Post-operative Pre-operative Post-operative
WASI (SS)
FSIQ 91.6 (14.1) 94.6 (14.2) 98.2 (10.0) 96.5 (8.4)
VIQ 88.3 (11.9) 90.7 (12.8) 93.1 (11.9) 87.0 (9.6)
PIQ 93.7 (17.4) 97.3 (18.3) 104.0 (9.0) 106.6 (8.3)
WAIS-III (ACSS)
Digit Span 8.4 (3.0) 8.2 (2.8) 9.2 (3.5) 9.3 (3.0)
Coding 9.0 (1.9) 8.9 (3.7) 8.2 (2.7) 8.6 (3.0)
Trail Making Test (T-score)
Trails A 41.5 (11.7) 48.2 (13.6) 43.7 (13.9) 44.6 (12.6)
Trails B 40.0 (13.4) 44.4 (14.8) 47.3 (14.8) 48.6 (11.3)
BNT (T-score) 37.0 (11.4) 41.3 (12.7) 34.8 (11.0) 31.2 (9.6)
BVMT-R (T-score)
Learning 34.9 (13.7) 35.6 (13.7) 45.0 (12.3) 42.7 (12.6)
Delay 36.0 (14.9) 34.8 (15.4) 45.1 (12.7) 42.5 (14.4)
RAVLT (T-score)
Learning 43.4 (11.8) 46.2 (11.4) 40.0 (13.6) 38.3 (12.0)
Delay 44.6 (13.2) 46.1 (14.7) 39.9 (15.0) 37.4 (15.7)
Finger Tapping Test (T-score)
Right 45.5 (7.2) 41.6 (8.7) 47.6 (11.6) 48.9 (11.1)
Left 46.1 (9.5) 43.4 (9.7) 47.2 (12.2) 50.3 (11.8)
BDI-2 (raw score) 9.1 (7.8) 5.9 (5.6) 15.5 (11.7) 12.0 (10.7)
Note: Mean and standard deviation (SD) are provided for each variable.
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Postoperatively, impaired scores were noted in half of left SAH
patients and approximately one quarter of right SAH patients for
the RAVLT-Learning and Delay. The high rates of preoperative
impairment on the RAVLT may in part explain low rates of
significant post-operative change on this measure.
4. Discussion
The aim of the present study was to evaluate post-surgical
neurocognitive outcome using reliable change scores at the 90%
confidence interval and to identify rates of decline following
subtemporal SAH in the largest sample to date. Use of reliable
change scores indicated a significant number of patients
experienced post-operative neurocognitive decline following
subtemporal SAH which is in contrast to previous studies group
level analyses. Dominant hemisphere surgery presented the
greatest risk for neurocognitive decline across the highest
number of domains with one-third of patients showing decline
in memory, verbal intellect, and naming. Visuospatial memory
decline was noted in 36% of non-dominant SAH patients, but
there were low rates of decline in other cognitive domains. Post-
operative gain was most common following non-dominant SAH
including better performance on measures of global intellect,
processing speed, and naming. In contrast, significant gain
following dominant SAH was primarily noted on one of two
measures of processing speed. At the group level, there was no
significant neurocognitive changes based on side of SAH,
presence/absence of MTS, or presence/absence of post-operative
seizure. In this sample, approximately 75% of patients were
seizure free at an average of 7 months following surgery, which is
similar to seizure control rates noted by other studies.4,42,43
However, based on the archival nature of these data, Engle class
could not be reliably rated. Overall, findings indicated sub-
temporal SAH can produce good short-term post-operative
seizure control and high rates of stable post-operative neuro-
cognitive performance with the greatest risk for neurocognitive
decline associated with dominant hemisphere surgery.
Conflicting findings have been obtained by prior studies
comparing neuropsychological outcome following ATL and
SAH.14,44–50 Some evidence suggests more extensive resections
may result in greater memory impairment at least in regards to
verbal memory and left hemisphere resections.14,44–47 For exam-
ple, Helmstaedter et al.47 noted better verbal memory outcome in
left resection when the temporal stem was spared by combined
temporo-polar and amygdalohippocampectomy resection as
compared to a standard ATL. In the case of a right resection, the
lowest decline in nonverbal memory was obtained by sparing
neocortical tissue through a transsylvian SAH. In regards to short-
term group level outcomes (<12 months post surgery), a decline in
verbal memory is often noted at least for left sided resec-
tions.10,15,26,28,43 Longitudinal data generally suggests there may
be a post-operative decline in verbal memory, and in some cases
intellect, but typically neurocognitive functions remain fairly
stable and in some cases show mild improvement 2 or more years
post surgery.51,52 Use of a transsylvian or transcortical SAH has
shown a similar pattern of performance with a group level decline
in verbal memory for left SAH patients but otherwise generally
stable performance for attention, executive, and nonverbal
memory at a short-term follow-up without a significant difference
by surgical approach.15 Unfortunately, a direct comparison has not
been made between subtemporal, transsylvian, and transcortical
SAH. Short-term outcome following subtemporal SAH has shown a
similar pattern to findings with other approaches to SAH or ATL.
Hori et al.28 noted stable or improved intellect and verbal memory
at 2 and 24 months post SAH with the exception of a verbal
memory decline following dominant subtemporal SAH. Robinson
et al.26 showed stable or improved performance for intellect,
naming, and story memory. However, a decline was noted for rote
verbal memory following dominant subtemporal SAH and a small
decline in design memory following non-dominant subtemporal
SAH. In the present study, stable group level performance across
neurocognitive functions but notable decline in aspects of
neurocognitive functions based on reliable change scores was
observed following left more than right subtemporal SAH.
However, it is possible the post-operative decline based on
reliable change scores for VIQ, naming, and memory may resolve
by 2 years post surgery as was noted by other researchers. Other
subtemporal SAH studies however did not use reliable change
scores and consequently, long-term outcome regarding individual
change was not available.
Although nonverbal memory decline was noted in 36% of
patients that underwent right SAH, performance deficits were
essentially limited to this one cognitive domain. In contrast,
patients with a dominant hemisphere surgery appeared to be at
the greatest risk for cognitive decline across multiple neurocog-
nitive domains including memory (nonverbal), verbal intellect,
and naming (29–38% of patients). These results are generally
consistent with risk for cognitive decline reported by prior
research with other surgical approaches for SAH. In addition,
presence of greatest risk for cognitive decline following dominant
hemisphere surgery was also consistent with prior research. There
has only been one prior study8 investigating outcome by use of a
reliable change approach in patients with a subtemporal SAH;
however, that sample was less than half the size (n = 18) of the
present sample (n = 47). The current findings expand on the
previous study by suggesting a greater risk for memory decline
following subtemporal SAH than was previously reported by Little
et al.8 However, differences in obtained results may be multifac-
torial and may include the differences in sample size and memory
tests used. For example, the Little et al.8 study used either the
RAVLT (as in the present study) or the California Verbal Learning
Test-2 (CVLT-2) to measure verbal memory and either the BVMT-R
(as in the present study) or the Rey-Osterrieth Complex Figure Test
(RCFT) to measure non-verbal memory but it was not clear what
proportion of patients were given which verbal or non-verbal
memory test. The present study used the same verbal memory and
the same non-verbal memory test for all patients and consequent-
ly, differences in test stimuli, psychometric properties, and
normative data were less likely to introduce error into the
obtained results. Finally, in regards to memory, the present study
suggested a notable proportion (30%) of patients experienced a
post-operative decline when reliable change scores were used and,
therefore, subtemporal SAH is not without risks to memory,
naming, and verbal intellectual functioning in individual patients
depending on side of surgery.
Table 5
Frequency of preoperative and postoperative learning and memory impaired scores
(1 SD).
Variable Right SAH
(n = 22)
Left SAH
(n = 25)
x2 p
Preoperative
BVMT-R Learning 15 (68.2%) 7 (28%) 7.59 0.01
BVMT-R Delay 14 (63.6%) 6 (24%) 7.52 0.01
RAVLT-Learning 7 (31.8%) 14 (58.3%) 3.25 0.07
RAVLT-Delay 5 (22.7%) 12 (50%) 3.66 0.06
Postoperative
BVMT-R Learning 14 (63.6%) 11 (44%) 1.81 0.18
BVMT-R Delay 13 (59.1%) 9 (36%) 2.51 0.11
RAVLT-Learning 6 (27.3%) 13 (52%) 2.97 0.09
RAVLT-Delay 6 (27.3%) 14 (56%) 3.95 0.05
Note: Frequency and percentages are presented.
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Both right and left SAH groups showed a decline in nonverbal
memory in approximately one third of patients but only a small
number of patients showed decline in verbal learning and memory.
Decline in nonverbal memory following both dominant and non-
dominant SAH has been noted by prior studies;12,13,53–55 however,
use of the BVMT-R as a measure of nonverbal memory may at least
in part account for this finding. Nonverbal memory tests have been
criticized in the past because the stimuli may be encoded and
recalled by both verbal and visual means resulting in poor
sensitivity to unilateral temporal lobe dysfunction. Consequently,
surgical intervention in either temporal lobe may reduce encoding
and recall for information that can be stored by either modality. In
the only prior study using the BVMT-R in an epilepsy sample,59 this
test was found to be a poor predictor of unilateral TLE and
consequently may function as a general as opposed to material
specific test of memory. Still, the prior study did not use reliable
change scores and compared groups rather than individuals. The
reason for very limited verbal memory decline but notable non-
verbal memory decline following SAH in the present study was
unclear. However, psychometric differences between these tests
(e.g., standard deviation, test–retest reliability) may have made it
more difficult to reach statistically significant change on the
RAVLT. In addition, high rates of baseline impairment on the RAVLT
may also be a contributing factor. Since rates of unilateral MTS
ipsilateral to surgical resection and recurrence of seizures did not
significantly differ between SAH groups these factors were unlikely
to explain limited verbal memory decline but notable non-verbal
memory decline in both seizure groups.
Specific to the subtemporal approach, statistical comparisons at
the group level were generally consistent with prior neurocogni-
tive outcome research.8,25–29 Although there was no evidence of
cognitive decline at the group level, unlike prior outcome studies,
there was no evidence of significant post-operative improvement
either.15,47,56–58 The disparity in findings between group level
analyses and reliable change analyses were important to note.
Group level analyses are commonly employed; however, unlike
reliable change analyses, they make no correction for each
patient’s individual baseline (preoperative) performance, practice
effects from taking the tests more than once, and the specific
amount of measurement error inherent to each individual
cognitive test. Consequently, individual post-operative changes
are likely to be attenuated at the group level given the lack of
accounting for the prior confounds whereas reliable change
analyses are likely to provide a more accurate estimate of post-
operative change. In the present study it was clear that although
group level analyses showed non-significant pre to postoperative
change, substantial individual change was noted in a subset of
patients when baseline performance, practice effect, and mea-
surement error were accounted for.
Presence of notable confrontation naming and verbal intellect
decline following dominant hemisphere surgery was not a new
finding; however, use of a subtemporal approach with preserva-
tion of lateral neocortical tissue and the temporal stem was
expected to limit changes in language and executive functions.
Current findings indicate that despite no resection of lateral
neocortical tissue and preservation of the temporal stem, language
disturbance still may occur in approximately one third of patients
that undergo dominant temporal lobe SAH. Disruption of the
‘‘basal temporal language area’’ (which includes the inferior
temporal, fusiform, and parahippocampal gyri) may be one
mechanism by which post-operative naming decline occurs.29,59
Studies have indicated intraoperative cortical stimulation of the
ventral temporal lobe can disrupt language functions (including
naming)29,60–62 and their disruption may underlie post-operative
naming impairment. Alternatively, neurocognitive functioning,
including language and memory, involve various neural net-
works63–65 and disruption of these networks may result in decline
in neurocognitive function.66 Further, presence of a postoperative
decline in VIQ was somewhat unexpected since this score was
based primarily on knowledge based tests. However, the observed
VIQ decline may be related to reduced naming ability as evidenced
by a significant correlation between the postoperative BNT score
and the VIQ reliable change score (r = 0.436, p < .01). This finding
may be explained by findings from prior studies67,68 which noted
post-operative language decline accounted for post-operative
verbal memory decline. Alternatively, in a small sample of patients
post subtemporal SAH at our center,69 cortical thinning was noted
postoperatively in the ipsilateral inferior temporal gyrus in the
area of postoperative edema following retraction. It is possible that
even with minimal retraction used in subtemporal SAH, postoper-
ative cognitive decline may be associated with cortical thinning as
opposed to hippocampal resection alone. In the present study, it
appears that resection of mesial temporal structures or possibly
retraction, even with minimal cortical disruption, may sufficiently
interfere with language networks to produce postoperative
language decline.
Limitations of the present study include fewer right SAH
compared to left SAH patients, insufficient data to establish Engle
classification, and multiple statistical comparisons. Fewer right
SAH cases were included in this study which has the potential of
influencing obtained results. This was not due to inequality in case
exclusion but rather a product of the patients that returned for
postoperative evaluation. It is possible a greater number of left SAH
patients returned for follow-up evaluation due to greater concern
regarding postoperative decline; although, rates of cognitive
decline in right and left SAH from the present study were generally
commensurate with other studies using reliable change scores.
Another limitation of the present study, and directly related to its
archival nature, was the inability to assign Engle class which
significantly limits comments on seizure outcome. Consequently,
patients were identified as either seizure free or having presence of
recurrent seizures (1 or more seizures) and it is possible a portion
of those identified as having recurrent seizures would still be
classified as Engle class 1.
In conclusion, the present study, which measured changes in
cognition via reliable change scores and expanded on previous
findings in the largest sample to date, indicated the majority of
patients that underwent subtemporal SAH experienced no
significant cognitive decline and most experienced good short-
term seizure control. However, through use of reliable change
analyses, memory decline was found in approximately 30% of
patients which is in marked contrast to prior studies using only
group level analyses in subtemporal SAH. These findings highlight
the importance of using reliable change procedures in outcome
research. Further, despite the preservation of the temporal stem
and minimal neocortical resection in subtemporal SAH, there
remains a naming decline in more than one third of patients that
undergo dominant hemisphere SAH. Together, these results
indicate that a notable proportion of subtemporal SAH patients
experience post-operative memory and naming decline with rates
similar to other reported surgical approaches. Dominant sub-
temporal SAH patients appear to be at the greatest risk for
cognitive decline in multiple cognitive domains. Direct comparison
between subtemporal SAH and another surgical approach (e.g.,
anterior temporal lobectomy, transsylvian SAH, or transcortical
SAH) is an important area for future research in order to assess if
rates of neurocognitive decline vary as a function of surgical
approach.
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